Literature DB >> 16436937

Sleep disturbances and depression: a challenge for antidepressants.

Raymond W Lam1.   

Abstract

Sleep disturbances are commonly experienced by depressed patients, and abnormalities of sleep architecture are among the most robust psychobiological correlates of major depression. Most antidepressants alter the physiological patterns of sleep and eventually improve sleep symptoms, along with other symptoms of depression. However, many antidepressants also have unwanted adverse effects on sleep, notably by causing or worsening insomnia, daytime sleepiness or sedation. This article briefly reviews the biology of sleep, the sleep disturbances associated with depression, and the therapeutic and adverse effects of antidepressants on sleep. It also describes a novel antidepressant, agomelatine, which improves symptoms of depression and rapidly relieves sleep complaints without sedative effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436937     DOI: 10.1097/01.yic.0000195658.91524.61

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  30 in total

1.  Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection.

Authors:  Venkatramanujam Srinivasan; Daniel P Cardinali; Uddanapalli S Srinivasan; Charanjit Kaur; Gregory M Brown; D Warren Spence; Rüdiger Hardeland; Seithikurippu R Pandi-Perumal
Journal:  Ther Adv Neurol Disord       Date:  2011-09       Impact factor: 6.570

2.  Association Between Nonmedical Use of Prescription Drugs and Sleep Quality in a Large College Student Sample.

Authors:  Yahya A Alamir; Keith J Zullig; Sijin Wen; Hawley Montgomery-Downs; Alfgeir L Kristjansson; Ranjita Misra; Jianjun Zhang
Journal:  Behav Sleep Med       Date:  2017-12-22       Impact factor: 2.964

3.  Depressive symptoms are associated with poor sleep quality rather than apnea-hypopnea index or hypoxia during sleep in patients with obstructive sleep apnea.

Authors:  Sang Hun Lee; Yu Jin Lee; Soohyun Kim; Jae-Won Choi; Do-Un Jeong
Journal:  Sleep Breath       Date:  2017-08-19       Impact factor: 2.816

4.  Antagonistic Serotonergic and Octopaminergic Neural Circuits Mediate Food-Dependent Locomotory Behavior in Caenorhabditis elegans.

Authors:  Matthew A Churgin; Richard J McCloskey; Emily Peters; Christopher Fang-Yen
Journal:  J Neurosci       Date:  2017-07-11       Impact factor: 6.167

5.  Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report.

Authors:  Sharon C Sung; Stephen R Wisniewski; James F Luther; Madhukar H Trivedi; A John Rush
Journal:  J Affect Disord       Date:  2014-11-22       Impact factor: 4.839

6.  Altered sleep architecture and higher incidence of subsyndromal depression in low endogenous melatonin secretors.

Authors:  Shadab Ataur Rahman; Shai Marcu; Leonid Kayumov; Colin Michael Shapiro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-12-18       Impact factor: 5.270

7.  Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications.

Authors:  Shanna L Burke; Tianyan Hu; Christine E Spadola; Tan Li; Mitra Naseh; Aaron Burgess; Tamara Cadet
Journal:  Sleep Med       Date:  2018-09-20       Impact factor: 3.492

8.  Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways.

Authors:  Daniela Tardito; Marco Milanese; Tiziana Bonifacino; Laura Musazzi; Massimo Grilli; Alessandra Mallei; Elisabeth Mocaer; Cecilia Gabriel-Gracia; Giorgio Racagni; Maurizio Popoli; Giambattista Bonanno
Journal:  BMC Neurosci       Date:  2010-06-03       Impact factor: 3.288

9.  The relationship between depressive symptoms and obstructive sleep apnea in pediatric populations: a meta-analysis.

Authors:  Elif Yilmaz; Karim Sedky; David S Bennett
Journal:  J Clin Sleep Med       Date:  2013-11-15       Impact factor: 4.062

Review 10.  Role of the melatonin system in the control of sleep: therapeutic implications.

Authors:  Seithikurippu R Pandi-Perumal; Venkatramanujan Srinivasan; D Warren Spence; Daniel P Cardinali
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.